S2C (p.Ser2Cys) variant of MAGED2 (Melanoma-associated antigen D2)

S2C (p.Ser2Cys) in MAGED2 (Melanoma-associated antigen D2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data and structural context.

S2C (p.Ser2Cys) variant details